Jinrui Wei

Nanning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Oliceridine used for patient-controlled analgesia on postoperative quality of recovery in patients undergoing laparoscopic gynecological tumour resection: a randomized clinical trial.

Oliceridine used for patient-controlled analgesia on postoperative quality of recovery in patients undergoing laparoscopic gynecological tumour resection: a randomized clinical trial.

Journal: Annals of medicine

Published: August 12, 2026

Arnicolide C induces ferroptosis in liver cancer through modulation of the HMOX1-TRC8 axis.

Arnicolide C induces ferroptosis in liver cancer through modulation of the HMOX1-TRC8 axis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 13, 2025

Deep learning predicts and in vitro experiments validates the synergistic anti-liver cancer effect of vincristine and lenvatinib: Mechanism involving apoptosis induction via the TNF-α/Caspase-8 pathway.

Deep learning predicts and in vitro experiments validates the synergistic anti-liver cancer effect of vincristine and lenvatinib: Mechanism involving apoptosis induction via the TNF-α/Caspase-8 pathway.

Journal: Biochemical and biophysical research communications

Published: October 28, 2025

ResiDUBs: A deubiquitinating enzyme-based prognostic model identifies UBXN1 driving sorafenib resistance in liver cancer.

ResiDUBs: A deubiquitinating enzyme-based prognostic model identifies UBXN1 driving sorafenib resistance in liver cancer.

Journal: International immunopharmacology

Published: October 04, 2025

From computational prediction to in vitro experimental validation: Identifying active compounds in longan leaves and their anti-colorectal cancer mechanisms.

From computational prediction to in vitro experimental validation: Identifying active compounds in longan leaves and their anti-colorectal cancer mechanisms.

Journal: Fitoterapia

Published: September 28, 2025

PathSynergy: a deep learning model for predicting drug synergy in liver cancer.

PathSynergy: a deep learning model for predicting drug synergy in liver cancer.

Journal: Briefings in bioinformatics

Published: December 25, 2024

Centipeda minima extract exhibits anti-liver cancer effects via the ER stress/HMOX1/Fe2+/ROS pathway.

Centipeda minima extract exhibits anti-liver cancer effects via the ER stress/HMOX1/Fe2+/ROS pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: September 04, 2024

Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation.

Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation.

Journal: Gene

Published: December 18, 2023

Sophoridine derivative 6j inhibits liver cancer cell proliferation via ATF3 mediated ferroptosis.

Sophoridine derivative 6j inhibits liver cancer cell proliferation via ATF3 mediated ferroptosis.

Journal: Cell death discovery

Published: March 29, 2023

A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma.

A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: January 17, 2023

Integrated analysis identified NPNT as a potential key regulator in tumor metastasis of hepatocellular carcinoma.

Integrated analysis identified NPNT as a potential key regulator in tumor metastasis of hepatocellular carcinoma.

Journal: Gene

Published: November 25, 2021

Knockdown of RFC4 inhibits the cell proliferation of nasopharyngeal carcinoma in vitro and in vivo.

Knockdown of RFC4 inhibits the cell proliferation of nasopharyngeal carcinoma in vitro and in vivo.

Journal: Frontiers of medicine

Published: October 26, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026